Diagnostic Ultrasound - Abdomen and Pelvis

09.07.2019 Views

Ovarian Metastases Including Krukenberg Tumor TERMINOLOGY Definitions • Secondary (metastatic) neoplasms to ovary • Krukenberg tumor ○ Subtype of metastatic tumors that contain > 10% mucinfilled signet cells in cellular stroma ○ Usually from gastrointestinal tract, with 76% arising from stomach ○ Krukenberg tumor is sometimes used inappropriately by some to include all metastatic ovarian carcinomas • High-stage mucinous tumors involving ovary frequently represent metastases from extraovarian primary sites and are often misdiagnosed as primary ovarian mucinous tumors IMAGING General Features • Best diagnostic clue ○ Bilateral ovarian masses in patients with known primary carcinoma ○ Metastases to ovary are usually solid masses – However, cystic and necrotic areas can be seen and tumors may resemble primary ovarian cancer • Location ○ Usually bilateral ○ Majority of metastases from colon are bilateral (80%) – If unilateral, more common in right ovary • Size ○ Often large masses • Morphology ○ Lobulated masses with smooth external contour – 92% of ovarian metastases from colon cancer show smooth margin compared with 45% of primary ovarian cancers ○ Nonspecific imaging features in isolation Ultrasonographic Findings • Grayscale ultrasound ○ Ovarian mass ○ Solid or cystic and solid – Rarely unilocular cyst – May be complicated by hemorrhage – May mimic mucinous cystadenocarcinoma with multiple locules • Color Doppler ○ Solid components demonstrate variable vascularity CT Findings • NECT ○ Metastatic ovarian tumors often have soft tissue density but may demonstrate low-attenuation cystic or necrotic areas • CECT ○ Solid components often demonstrate heterogeneous enhancement ○ Cystic and necrotic areas do not enhance ○ Metastatic colorectal carcinoma may appear as multilocular cystic lesion with stained-glass appearance – Loculi with variable attenuation – Mimics primary mucinous ovarian cancer MR Findings • T1WI ○ Solid components demonstrate intermediate signal intensity • T2WI ○ Solid components demonstrate heterogeneous signal intensity ○ Cystic and necrotic components demonstrate high signal intensity ○ Loculi within multilocular tumors may show variable signal intensities • T1WI C+ ○ Solid components show marked heterogeneous enhancement Nuclear Medicine Findings • PET ○ PET/CT is modality of choice for tumor staging and shows variable increased metabolic uptake in ovarian metastases Imaging Recommendations • Best imaging tool ○ Ultrasound is usually 1st modality to demonstrate ovarian involvement in patient with known malignancy ○ CT and MR can be used to assess extent of disease DIFFERENTIAL DIAGNOSIS Primary Ovarian Cancer • Most primary ovarian carcinomas are predominantly cystic masses ○ Multilocularity of cystic mass suggests primary ovarian tumor • Most secondary malignancies of ovary are predominantly solid or mixture of solid and cystic areas Ovarian Lymphoma • Ovarian lymphomas are often homogeneous solid masses • Extensive involvement of lymph node chains is seen in lymphoma PATHOLOGY General Features • Etiology ○ Metastases to ovary occur by hematogenous, lymphatic, transperitoneal, or direct extension ○ Primary sites of nongynecologic tumors – Colon (30%) □ Metastatic colon cancers to ovary usually arise from distal lesions, most commonly rectosigmoid, followed in decreasing order by transverse colon, ascending colon, cecum, and descending colon – Stomach (16%), appendix (13%), breast (13%), pancreas (12%), biliary tract (15%), and liver (4%) ○ Common gynecologic primary sites – Uterine body (23%), uterine cervix (4%) Staging, Grading, & Classification • Staging is based on staging system of primary malignancy Diagnoses: Female Pelvis 861

Ovarian Metastases Including Krukenberg Tumor Diagnoses: Female Pelvis Gross Pathologic & Surgical Features • Cut surfaces of ovaries may be solid, solid-cystic, or multicystic • Have tendency to preserve contour of ovary • Hemorrhage or necrosis may be present within mass Microscopic Features • Hyperplasia of ovarian stromal cells with significant number of signet ring cells • Features favoring metastatic rather than primary ovarian neoplasm include ○ Bilaterality ○ Nodular pattern of ovarian involvement ○ Infiltrative pattern of stromal invasion ○ Microscopic surface deposits of tumor ○ Marked lymphovascular invasion (especially in hilum and outside ovary) ○ Signet ring cells ○ Cells floating in mucin ○ Variation in growth pattern from 1 nodule to another • Due to high risk of ovarian metastasis, palliative bilateral oophorectomy may be performed during surgery for colon cancer DIAGNOSTIC CHECKLIST Consider • Imaging findings of primary ovarian cancer and metastases to ovaries overlap in many cases, and confident imaging distinction between the 2 may be challenging • In patients with metastases to ovaries, primary tumor is often clinically overt and associated with findings of widespread metastatic disease • Investigation of gastrointestinal tract is recommended in patient without known primary cancer Image Interpretation Pearls • Features that are more often seen in metastases to ovary include ○ Bilateral ovarian masses ○ Predominantly solid appearance of mass CLINICAL ISSUES Presentation • Most common signs/symptoms ○ Abdominal pain ○ Palpable pelvic masses • Other signs/symptoms ○ Occasionally associated hormonal activity can be seen due to reactive ovarian stromal hyperplasia • Clinical profile ○ In many cases, there is known history of primary neoplasm ○ Usually symptoms of primary disease precede symptoms secondary to ovarian metastasis ○ On occasion, presentation is with symptoms related to ovarian mass in patient with no known history of malignancy Demographics • Age ○ More common in premenopausal women due to vascularity of ovaries • Epidemiology ○ 5-15% of malignant ovarian tumors are metastatic tumors to ovary ○ 5-30% of cancer patients have ovarian metastases at autopsy ○ Only 30-40% of ovarian metastases are true Krukenberg tumors Natural History & Prognosis • Poor prognosis with mortality rate of ~ 90% 1 year after ovarian metastasis is discovered • Krukenburg tumors: Mean survival 23 months ○ Premenopausal patients and metachronous lesions fair better Treatment • Radical tumor-reductive surgery • Often have poor response to chemotherapy SELECTED REFERENCES 1. Jeung YJ et al: Krukenberg tumors of gastric origin versus colorectal origin. Obstet Gynecol Sci. 58(1):32-9, 2015 2. Nakamura Y et al: A Krukenberg Tumor from an Occult Intramucosal Gastric Carcinoma Identified during an Autopsy. Case Rep Oncol Med. 2014:797429, 2014 3. Alvarado-Cabrero I et al: Metastatic ovarian tumors: a clinicopathologic study of 150 cases. Anal Quant Cytol Histol. 35(5):241-8, 2013 4. La Fianza A et al: Intralesional hemorrhage in Krukenberg tumor: a case report and review of the literature. J Ultrasound. 16(2):89-91, 2013 5. Guerriero S et al: Preoperative diagnosis of metastatic ovarian cancer is related to origin of primary tumor. Ultrasound Obstet Gynecol. 39(5):581-6, 2012 6. Ho L et al: Bilateral ovarian metastases from gastric carcinoma on FDG PET/CT. Clin Nucl Med. 37(5):524-7, 2012 7. Willmott F et al: Radiological manifestations of metastasis to the ovary. J Clin Pathol. 65(7):585-90, 2012 8. Kitajima K et al: FDG PET/CT features of ovarian metastasis. Clin Radiol. 66(3):264-8, 2011 9. Maeda-Taniguchi M et al: Metastatic mucinous adenocarcinoma of the ovary is characterized by advanced patient age, small tumor size, and elevated serum CA125. Gynecol Obstet Invest. 72(3):196-202, 2011 10. de Waal YR et al: Secondary ovarian malignancies: frequency, origin, and characteristics. Int J Gynecol Cancer. 19(7):1160-5, 2009 11. Koyama T et al: Secondary ovarian tumors: spectrum of CT and MR features with pathologic correlation. Abdom Imaging. 32(6):784-95, 2007 12. Testa AC et al: Imaging in gynecological disease (1): ultrasound features of metastases in the ovaries differ depending on the origin of the primary tumor. Ultrasound Obstet Gynecol. 29(5):505-11, 2007 13. Chang WC et al: CT and MRI of adnexal masses in patients with primary nonovarian malignancy. AJR Am J Roentgenol. 186(4):1039-45, 2006 14. Khunamornpong S et al: Primary and metastatic mucinous adenocarcinomas of the ovary: Evaluation of the diagnostic approach using tumor size and laterality. Gynecol Oncol. 101(1):152-7, 2006 15. Kiyokawa T et al: Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol. 30(3):277-99, 2006 16. Alcazar JL et al: Transvaginal gray scale and color Doppler sonography in primary ovarian cancer and metastatic tumors to the ovary. J Ultrasound Med. 22(3):243-7, 2003 17. Jung SE et al: CT and MR imaging of ovarian tumors with emphasis on differential diagnosis. Radiographics. 22(6):1305-25, 2002 18. Brown DL et al: Primary versus secondary ovarian malignancy: imaging findings of adnexal masses in the Radiology Diagnostic Oncology Group Study. Radiology. 219(1):213-8, 2001 19. Hann LE et al: Adnexal masses in women with breast cancer: US findings with clinical and histopathologic correlation. Radiology. 216(1):242-7, 2000 862

Ovarian Metastases Including Krukenberg Tumor<br />

Diagnoses: Female <strong>Pelvis</strong><br />

Gross Pathologic & Surgical Features<br />

• Cut surfaces of ovaries may be solid, solid-cystic, or<br />

multicystic<br />

• Have tendency to preserve contour of ovary<br />

• Hemorrhage or necrosis may be present within mass<br />

Microscopic Features<br />

• Hyperplasia of ovarian stromal cells with significant number<br />

of signet ring cells<br />

• Features favoring metastatic rather than primary ovarian<br />

neoplasm include<br />

○ Bilaterality<br />

○ Nodular pattern of ovarian involvement<br />

○ Infiltrative pattern of stromal invasion<br />

○ Microscopic surface deposits of tumor<br />

○ Marked lymphovascular invasion (especially in hilum <strong>and</strong><br />

outside ovary)<br />

○ Signet ring cells<br />

○ Cells floating in mucin<br />

○ Variation in growth pattern from 1 nodule to another<br />

• Due to high risk of ovarian metastasis, palliative bilateral<br />

oophorectomy may be performed during surgery for colon<br />

cancer<br />

DIAGNOSTIC CHECKLIST<br />

Consider<br />

• Imaging findings of primary ovarian cancer <strong>and</strong> metastases<br />

to ovaries overlap in many cases, <strong>and</strong> confident imaging<br />

distinction between the 2 may be challenging<br />

• In patients with metastases to ovaries, primary tumor is<br />

often clinically overt <strong>and</strong> associated with findings of<br />

widespread metastatic disease<br />

• Investigation of gastrointestinal tract is recommended in<br />

patient without known primary cancer<br />

Image Interpretation Pearls<br />

• Features that are more often seen in metastases to<br />

ovary include<br />

○ Bilateral ovarian masses<br />

○ Predominantly solid appearance of mass<br />

CLINICAL ISSUES<br />

Presentation<br />

• Most common signs/symptoms<br />

○ Abdominal pain<br />

○ Palpable pelvic masses<br />

• Other signs/symptoms<br />

○ Occasionally associated hormonal activity can be seen<br />

due to reactive ovarian stromal hyperplasia<br />

• Clinical profile<br />

○ In many cases, there is known history of primary<br />

neoplasm<br />

○ Usually symptoms of primary disease precede symptoms<br />

secondary to ovarian metastasis<br />

○ On occasion, presentation is with symptoms related to<br />

ovarian mass in patient with no known history of<br />

malignancy<br />

Demographics<br />

• Age<br />

○ More common in premenopausal women due to<br />

vascularity of ovaries<br />

• Epidemiology<br />

○ 5-15% of malignant ovarian tumors are metastatic<br />

tumors to ovary<br />

○ 5-30% of cancer patients have ovarian metastases at<br />

autopsy<br />

○ Only 30-40% of ovarian metastases are true Krukenberg<br />

tumors<br />

Natural History & Prognosis<br />

• Poor prognosis with mortality rate of ~ 90% 1 year after<br />

ovarian metastasis is discovered<br />

• Krukenburg tumors: Mean survival 23 months<br />

○ Premenopausal patients <strong>and</strong> metachronous lesions fair<br />

better<br />

Treatment<br />

• Radical tumor-reductive surgery<br />

• Often have poor response to chemotherapy<br />

SELECTED REFERENCES<br />

1. Jeung YJ et al: Krukenberg tumors of gastric origin versus colorectal origin.<br />

Obstet Gynecol Sci. 58(1):32-9, 2015<br />

2. Nakamura Y et al: A Krukenberg Tumor from an Occult Intramucosal Gastric<br />

Carcinoma Identified during an Autopsy. Case Rep Oncol Med. 2014:797429,<br />

2014<br />

3. Alvarado-Cabrero I et al: Metastatic ovarian tumors: a clinicopathologic study<br />

of 150 cases. Anal Quant Cytol Histol. 35(5):241-8, 2013<br />

4. La Fianza A et al: Intralesional hemorrhage in Krukenberg tumor: a case<br />

report <strong>and</strong> review of the literature. J <strong>Ultrasound</strong>. 16(2):89-91, 2013<br />

5. Guerriero S et al: Preoperative diagnosis of metastatic ovarian cancer is<br />

related to origin of primary tumor. <strong>Ultrasound</strong> Obstet Gynecol. 39(5):581-6,<br />

2012<br />

6. Ho L et al: Bilateral ovarian metastases from gastric carcinoma on FDG<br />

PET/CT. Clin Nucl Med. 37(5):524-7, 2012<br />

7. Willmott F et al: Radiological manifestations of metastasis to the ovary. J Clin<br />

Pathol. 65(7):585-90, 2012<br />

8. Kitajima K et al: FDG PET/CT features of ovarian metastasis. Clin Radiol.<br />

66(3):264-8, 2011<br />

9. Maeda-Taniguchi M et al: Metastatic mucinous adenocarcinoma of the ovary<br />

is characterized by advanced patient age, small tumor size, <strong>and</strong> elevated<br />

serum CA125. Gynecol Obstet Invest. 72(3):196-202, 2011<br />

10. de Waal YR et al: Secondary ovarian malignancies: frequency, origin, <strong>and</strong><br />

characteristics. Int J Gynecol Cancer. 19(7):1160-5, 2009<br />

11. Koyama T et al: Secondary ovarian tumors: spectrum of CT <strong>and</strong> MR features<br />

with pathologic correlation. Abdom Imaging. 32(6):784-95, 2007<br />

12. Testa AC et al: Imaging in gynecological disease (1): ultrasound features of<br />

metastases in the ovaries differ depending on the origin of the primary<br />

tumor. <strong>Ultrasound</strong> Obstet Gynecol. 29(5):505-11, 2007<br />

13. Chang WC et al: CT <strong>and</strong> MRI of adnexal masses in patients with primary<br />

nonovarian malignancy. AJR Am J Roentgenol. 186(4):1039-45, 2006<br />

14. Khunamornpong S et al: Primary <strong>and</strong> metastatic mucinous adenocarcinomas<br />

of the ovary: Evaluation of the diagnostic approach using tumor size <strong>and</strong><br />

laterality. Gynecol Oncol. 101(1):152-7, 2006<br />

15. Kiyokawa T et al: Krukenberg tumors of the ovary: a clinicopathologic<br />

analysis of 120 cases with emphasis on their variable pathologic<br />

manifestations. Am J Surg Pathol. 30(3):277-99, 2006<br />

16. Alcazar JL et al: Transvaginal gray scale <strong>and</strong> color Doppler sonography in<br />

primary ovarian cancer <strong>and</strong> metastatic tumors to the ovary. J <strong>Ultrasound</strong><br />

Med. 22(3):243-7, 2003<br />

17. Jung SE et al: CT <strong>and</strong> MR imaging of ovarian tumors with emphasis on<br />

differential diagnosis. Radiographics. 22(6):1305-25, 2002<br />

18. Brown DL et al: Primary versus secondary ovarian malignancy: imaging<br />

findings of adnexal masses in the Radiology <strong>Diagnostic</strong> Oncology Group<br />

Study. Radiology. 219(1):213-8, 2001<br />

19. Hann LE et al: Adnexal masses in women with breast cancer: US findings with<br />

clinical <strong>and</strong> histopathologic correlation. Radiology. 216(1):242-7, 2000<br />

862

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!